“…Endogenously expressed Piezo1 or Piezo2 confers exquisite mechanosensitivity to various cell types (Murthy et al, 2017;Xiao, 2019), including epithelial cells (Eisenhoffer et al, 2012;Gudipaty et al, 2017), endothelial cells (Li et al, 2014;Nonomura et al, 2018;Ranade et al, 2014a), smooth muscle cells (Retailleau et al, 2015), red blood cells (Zarychanski et al, 2012), chondrocytes (Servin-Vences et al, 2017), osteoblasts (Sun et al, 2019), merkel cells (Woo et al, 2014) and sensory neurons (Ranade et al, 2014b). Such Piezo-mediated mechanotransduction process controls a wide variety of key biological activities (Douguet and Honore, 2019;Murthy et al, 2017;Xiao, 2019), including epithelial homeostasis (Eisenhoffer et al, 2012;Gudipaty et al, 2017), vascular and lymphatic development and remodeling (Li et al, 2014;Nonomura et al, 2018;Ranade et al, 2014a), blood pressure regulation (Rode et al, 2017;Wang et al, 2016;Zeng et al, 2018), bone formation (Sun et al, 2019), and somatosensation of touch (Ranade et al, 2014b;Woo et al, 2014), balance (Woo et al, 2015), tactile pain Szczot et al, 2018) and breathing (Nonomura et al, 2017). Abnormal Piezo channel functions arising from genetic mutations have been associated with many human genetic diseases, including Piezo1-based dehydrated hereditary stomatocytosis (Zarychanski et al, 2012) and familial generalized lymphatic dysplasia (Fotiou et al, 2015;Lukacs et al, 2015), and Piezo2-based distal arthrogryposis <...>…”